Usine-AFYREN-NEOXY-fermenteurs crédits

AFYREN announces the industrial commissioning of its AFYREN NEOXY plant and publishes its 2021 Full-Year Results

AFYREN announces the industrial commissioning of its AFYREN NEOXY plant and publishes its 2021 Full-Year Results

  •  Finalization of the construction of the AFYREN NEOXY plant at cost and on time despite the health crisis context
  • Industrial commissioning of the plant with the launch of the test phase
  • Strong cash position of €67 million at the end of 2021 following the success of the IPO
  • Execution of the strategy in line with the plan presented at the IPO and confirmation of the financial outlook and objectives

Nicolas SORDET, AFYREN’s CEO, stated: “2021 was a transforming year for AFYREN, culminating in the IPO in September. The year 2022 also promises to be full of challenges and we are pleased to have met the first one with the launch of the industrial commissioning of our AFYREN NEOXY plant on the Carling Saint-Avold site, in accordance with the announced schedule and at cost. We now have the financial resources and a first industrial tool to accelerate the achievement of our Purpose, “We enable low-carbon, circular industry by providing biobased solutions built with our partners to benefit the environment”.”

 

Industrial commissioning of AFYREN NEOXY plant

In the second half of 2020, AFYREN launched the construction of AFYREN NEOXY, its first large-scale plant, located in Carling-Saint Avold, in the Grand Est region. AFYREN NEOXY is the first industrial-scale plant for the production of biobased carboxylic acids from sugar beet co-products.
Today, the construction phase for this plant is nearing completion: all the equipment has been delivered and the acceptance and start-up process is underway in accordance with the planned schedule. These tests will be spread out over several weeks for a gradual commissioning of the different equipment, a test phase that will prepare the launch of production.

Jean SAINT-DONAT, President of AFYREN NEOXY, adds: “The industrial commissioning of the AFYREN NEOXY plant is a key step in the history of AFYREN. We are ready to start and deliver the first batches of biobased acids developed with AFYREN technology this year. We are facing this transition to industrial scale with serenity alongside the fifty or so new employees already recruited and trained, and we are confirming our deep commitment to the environment by promoting short supply and sales channels thanks to our strategic geolocation in the heart of Europe.”

 

2021 key financial elements

Sales in 2021 amount to €3.04 million, against €3.99 million in 2020. The sales are essentially composed of income from the various contracts concluded with AFYREN NEOXY (patent and know-how licenses, services related to the obtaining of the BBI grant1 by AFYREN NEOXY, commercial and administrative assistance services).
As expected, the Company recorded a net loss in 2021, amounting to €3.61 million (compared to €2.13 million in 2020), as a consequence of the acceleration of investments prior to the operation of the industrial units.

 

Purpose and extra-financial rating significantly improved

Following several months of reflection and consultation with its internal and external stakeholders, AFYREN and its board of directors define and formalize its Purpose in early 2022: “We enable low-carbon, circular industry by providing biobased solutions built with our partners to benefit the environment.”

 

Full Press release:

Download

Latest News

AFYREN to offer differentiated sustainable solutions with the launch of new brands for its biobased products in several markets

The strategy responds to customers and stakeholders who are increasingly seeking more environmentally friendly solutions AFYREN’s move marks another step toward increasing visibility and recognition for its biobased products AFYREN’s biobased solutions have distinct advantages for each target market Clermont-Ferrand/Lyon, 17th of May 2022, 8:00 am CEST – AFYREN, a greentech company that manufactures biobased ingredients using fermentation technology and a circular business model, unveiled its plan to market high quality solutions that will help customers in the industries it serves meet their sustainability goals. AFYREN makes biobased carboxylic acids (C2-C6) that are needed in a wide variety of industries […]

Strategic contract signed for the supply of an organic acid from the AFYREN NEOXY range in animal nutrition

Thanks to its proven antimicrobial property, AFYREN’s biobased acid will enable its customer to contribute to animal health with its nutrition offerings for a wide variety of animal species. The customer will benefit from a short and reliable supply chain, and a product with a reduced carbon footprint, produced using sustainable renewable resources and without palm oil. AFYREN’s ingredient also meet requirements for GMO-free solutions in Europe. Full Press release:

AFYREN Webinar – Industrial Commissioning and Annual Results

Nicolas SORDET, CEO, Maxime CORDONNIER, CFO and Caroline PETIGNY, CSR & Communication Director of AFYREN as well as Jean SAINT-DONAT, President of AFYREN NEOXY presented their news during a webinar, in particular the industrial commissioning of the AFYREN NEOXY plant and the publication of the Company’s annual results. 

AFYREN announces the industrial commissioning of its AFYREN NEOXY plant and publishes its 2021 Full-Year Results

AFYREN announces the industrial commissioning of its AFYREN NEOXY plant and publishes its 2021 Full-Year Results  Finalization of the construction of the AFYREN NEOXY plant at cost and on time despite the health crisis context Industrial commissioning of the plant with the launch of the test phase Strong cash position of €67 million at the end of 2021 following the success of the IPO Execution of the strategy in line with the plan presented at the IPO and confirmation of the financial outlook and objectives Nicolas SORDET, AFYREN’s CEO, stated: “2021 was a transforming year for AFYREN, culminating in the […]

Green chemistry

Industry is transitioning to cleaner, greener ways. More than half of companies (51%) say they are committed to sustainability[1], yet it is clear that reconciling a lower environmental impact with economic success involves a lot of difficult choices — just 21% of companies have a clear roadmap for implementing their sustainability strategy. A more sustainable enterprise is rooted in several pillars, including responsible production, financing, procurement and marketing. Buyers, marketers, and investors need the right information to navigate an ocean of potential projects, understand their benefits and constraints and stand by their consequences. As recently underlined by Mc Kinsey, “it […]

AFYREN unveils its Purpose

Following several months of reflection and consultation with its internal and external stakeholders, AFYREN consulted, with the support of a specialized independent firm, all of its employees, through an online questionnaire or qualitative interviews, and conducted some fifteen interviews with suppliers, customers, institutions and partners. This analysis led to the definition of a materiality matrix, which ensures that the group’s ESG commitments and ambitions are aligned with the main aspects of its activity and the expectations of its stakeholders. This stakeholder consultation work also allowed AFYREN and its board of directors to define and formalize its Purpose: “We enable low-carbon, […]